1. Sharma D, Shastri S, Sharma P. Intrauterine Growth Restriction: Antenatal and Postnatal Aspects. Clin Med Insights Pediatr. 2016; 10:67-83. [
DOI:10.4137/CMPed.S40070] [
PMID] [
PMCID]
2. Kehl S, Dötsch J, Hecher K, Schlembach D, Schmitz D, Stepan H, et al. Intrauterine Growth Restriction. Guideline of the German Society of Gynecology and Obstetrics (S2k-Level, AWMF Registry No. 015/080, October 2016). Geburtshilfe Frauenheilkd. 2017; 77(11):1157-73. [
DOI:10.1055/s-0043-118908] [
PMID] [
PMCID]
3. Albu AR, Horhoianu IA, Dumitrascu MC, Horhoianu V. Growth assessment in diagnosis of Fetal Growth Restriction. Review. J Med Life. 2014; 7(2):150-4.
4. Albu AR, Anca AF, Horhoianu VV, Horhoianu IA. Predictive factors for intrauterine growth restriction. J Med Life. 2014; 7(2):165-71.
5. Puccio G, Giuffré M, Piccione M, Piro E, Rinaudo G, Corsello G. Intrauterine growth restriction and congenital malformations: a retrospective epidemiological study. Ital J Pediatr. 2013; 39:23. [
DOI:10.1186/1824-7288-39-23] [
PMID] [
PMCID]
6. Malhotra A, Allison BJ, Castillo-Melendez M, Jenkin G, Polglase GR, Miller SL. Neonatal Morbidities of Fetal Growth Restriction: Pathophysiology and Impact. Front Endocrinol (Lausanne). 2019; 10:55. [
DOI:10.3389/fendo.2019.00055] [
PMID] [
PMCID]
7. Krishna U, Bhalerao S. Placental insufficiency and fetal growth restriction. J Obstet Gynaecol India. 2011; 61(5):505-11. [
DOI:10.1007/s13224-011-0092-x] [
PMID] [
PMCID]
8. Bukowski R, Hansen NI, Willinger M, Reddy UM, Parker CB, Pinar H, et al. Fetal growth and risk of stillbirth: a population-based case-control study. PLoS Med. 2014; 11(4):e1001633. [
DOI:10.1371/journal.pmed.1001633] [
PMID] [
PMCID]
9. Pels A, Beune IM, van Wassenaer-Leemhuis AG, Limpens J, Ganzevoort W. Early-onset fetal growth restriction: A systematic review on mortality and morbidity. Acta Obstet Gynecol Scand. 2020; 99(2):153-66. [
DOI:10.1111/aogs.13702] [
PMID] [
PMCID]
10. Khanduri S, Chhabra S, Yadav S, Sabharwal T, Chaudhary M, Usmani T, et al. Role of Color Doppler Flowmetry in Prediction of Intrauterine Growth Retardation in High-Risk Pregnancy. Cureus. 2017; 9(11):e1827. [
DOI:10.7759/cureus.1827]
11. Stampalija T, Arabin B, Wolf H, Bilardo CM, Lees C. Is middle cerebral artery Doppler related to neonatal and 2-year infant outcome in early fetal growth restriction? Am J Obstet Gynecol. 2017; 216(5):521.
12. Menendez-Castro C, Rascher W, Hartner A. Intrauterine growth restriction - impact on cardiovascular diseases later in life. Mol Cell Pediatr. 2018; 5(1):4. [
DOI:10.1186/s40348-018-0082-5] [
PMID] [
PMCID]
13. Cohen E, Wong FY, Horne RS, Yiallourou SR. Intrauterine growth restriction: impact on cardiovascular development and function throughout infancy. Pediatr Res. 2016; 79(6):821-30. [
DOI:10.1038/pr.2016.24] [
PMID]
14. Crispi F, Bijnens B, Sepulveda-Swatson E, Cruz-Lemini M, Rojas-Benavente J, Gonzalez-Tendero A, et al. Postsystolic shortening by myocardial deformation imaging as a sign of cardiac adaptation to pressure overload in fetal growth restriction. Circ Cardiovasc Imaging. 2014 Sep; 7(5):781-7. [
DOI:10.1161/CIRCIMAGING.113.001490] [
PMID]
15. Moghadam EA, Zeinaloo A, Danaeian M, Hantoushzadeh S, Vahdani FG, Mazouri A, et al. The diagnosis of early fetal cardiac changes of the gestational diabetic mothers: Presenting the preload index. Iran J Pediatr. 2019;29(2).
16. Zhang L, Han J, Zhang N, Li Z, Wang J, Xuan Y, et al. Assessment of fetal modified myocardial performance index in early-onset and late-onset fetal growth restriction. Echocardiography. 2019; 36(6):1159-64. [
DOI:10.1111/echo.14364] [
PMID] [
PMCID]
17. Pacheco Silva C, Araujo Júnior E, Maccagnano Zamith M, Rabachini Caetano AC, Perez Zamarian AC, Oliveira Cavalcante R, et al. Assessment of modified myocardial performance index in foetuses with growth restriction. Med Ultrason. 2016; 18(2):207-13. [
DOI:10.11152/mu.2013.2066.182.idx] [
PMID]
18. Cruz-Martinez R, Figueras F, Benavides-Serralde A, Crispi F, Hernandez-Andrade E, Gratacos E. Sequence of changes in myocardial performance index in relation to aortic isthmus and ductus venosus Doppler in fetuses with early-onset intrauterine growth restriction. Ultrasound Obstet Gynecol. 2011; 38(2):179-84. [
DOI:10.1002/uog.8903] [
PMID]
19. Öcal DF, Yakut K, Öztürk FH, Öztürk M, Oğuz Y, Altınboğa O, et al. Utility of the modified myocardial performance index in growth-restricted fetuses. Echocardiography. 2019; 36(10):1895-900. [
DOI:10.1111/echo.14489] [
PMID]
20. Henry A, Alphonse J, Tynan D, Welsh AW. Fetal myocardial performance index in assessment and management of small-for-gestational-age fetus: a cohort and nested case-control study. Ultrasound Obstet Gynecol. 2018; 51(2):225-35. [
DOI:10.1002/uog.17476] [
PMID]
21. Masoumy EP, Sawyer AA, Sharma S, Patel JA, Gordon PMK, Regnault TRH, et al. The lifelong impact of fetal growth restriction on cardiac development. Pediatr Res. 2018; 84(4):537-44. [
DOI:10.1038/s41390-018-0069-x] [
PMID] [
PMCID]
22. Bendix I, Miller SL, Winterhager E. Editorial: Causes and Consequences of Intrauterine Growth Restriction. Front Endocrinol (Lausanne). 2020; 11:205. [
DOI:10.3389/fendo.2020.00205] [
PMID] [
PMCID]
23. Nair A, Radhakrishnan S. Fetal left ventricular myocardial performance index: Defining normal values for Indian population and a review of literature. Ann Pediatr Cardiol. 2016; 9(2):132-6. [
DOI:10.4103/0974-2069.177516] [
PMID] [
PMCID]
24. Cruz-Lemini M, Crispi F, Valenzuela-Alcaraz B, Figueras F, Gómez O, Sitges M, et al. A fetal cardiovascular score to predict infant hypertension and arterial remodeling in intrauterine growth restriction. Am J Obstet Gynecol. 2014; 210(6):552. [
DOI:10.1016/j.ajog.2013.12.031] [
PMID]
25. Bhorat IE, Bagratee JS, Pillay M, Reddy T. Determination of the myocardial performance index in deteriorating grades of intrauterine growth restriction and its link to adverse outcomes. Prenat Diagn. 2015; 35(3):266-73. [
DOI:10.1002/pd.4537] [
PMID]
26. Chawengsettakul S, Russameecharoen K, Wanitpongpan P. Fetal cardiac function measured by myocardial performance index of small-for-gestational age fetuses. J Obstet Gynaecol Res. 2015; 41(2):222-8. [
DOI:10.1111/jog.12508] [
PMID]
27. Bhorat I, Pillay M, Reddy T. The clinical prognostic significance of myocardial performance index (MPI) in stable placental-mediated disease. Cardiovasc J Afr. 2018; 29(5):310-6. [
DOI:10.5830/CVJA-2018-036] [
PMID]
28. Alici Davutoglu E, Ozel A, Oztunc F, Madazli R. Modified myocardial performance index and its prognostic significance for adverse perinatal outcome in early and late onset fetal growth restriction. J Matern Fetal Neonatal Med. 2020; 33(2):277-82. [
DOI:10.1080/14767058.2018.1489534] [
PMID]
29. Maheshwari P, Henry A, Welsh AW. The Fetal Modified Myocardial Performance Index: Is Automation the Future? Biomed Res Int. 2015; 2015:215910. [
DOI:10.1155/2015/215910] [
PMID] [
PMCID]
30. Patey O, Carvalho JS, Thilaganathan B. Perinatal changes in cardiac geometry and function in growth-restricted fetuses at term. Ultrasound Obstet Gynecol. 2019; 53(5):655-62. [
DOI:10.1002/uog.19193] [
PMID]